Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs United States Oil ETF (USO) Price & Performance

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade
United States Oil ETFTrade

Price performance (Past 24H)

Key statistics

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs United States Oil ETF — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B), while United States Oil ETF trades at $145.88 (market cap $1.83B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 31.8× United States Oil ETF's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while United States Oil ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and United States Oil ETF for 21 Days on average.

TAKUSO
Market Cap
$58.16B$1.83B
Volume
2,467,5303,073,172
Sector
Health—
52-Week High
$19.05$161.86
52-Week Low
$13.23$66.17
Typical Hold Time
0 Days21 Days
Enterprise Value
$86.04B—
Dividend Yield
3.36%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

No Aura AI signal available yet.

United States Oil ETF

USO trades at $143.91, down 0.7% amid mixed oil market signals. Technical indicators show neutral momentum with bearish moving averages, while geopolitical tensions and supply dynamics dominate sentiment. The stock faces resistance at $145 and support at $142, with recent news highlighting Middle East conflicts and OPEC+ production decisions affecting energy sector volatility.

The outlook remains uncertain with competing pressures from geopolitical risks and coordinated reserve releases. Investment opportunities exist if supply disruptions persist, but risks include potential price stabilization from G-7 interventions and broader market volatility. Current technical positioning suggests cautious near-term trading with key levels defining directional bias.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TAK
100% Buy0% Sell
Avg holding period · 0 Days
USO
35% Buy65% Sell
Avg holding period · 21 Days

Top news

Latest headlines on both assets

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →

About United States Oil ETF

This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.

Read more on USO →